Pet Cancer Therapeutics Market (By Medicine Type: Vaccines, Chemotherapy Drugs; By Species: Dogs, Cats; By Cancer Type: Melanoma, Squamous Cell Cancer, Mast Cell Cancer, Mammary, Lymphoma) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 160

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
       1.1.1. Definition of Pet Cancer Therapeutics
       1.1.2. Market Segmentation
       1.1.3. List of Abbreviations
1.2. Summary
       1.2.1. Market Snapshot
       1.2.2. Pet Cancer Therapeutics Market By Medicine Type
                 1.2.2.1. Global Pet Cancer Therapeutics Market Revenue and Growth Rate Comparison By Medicine Type (2015-2026)
                 1.2.2.2. Global Pet Cancer Therapeutics Market Revenue Share By Medicine Type in 2017
                 1.2.2.3. Vaccines
                 1.2.2.4. Chemotherapy Drugs
                 1.2.2.5. Others
       1.2.3. Pet Cancer Therapeutics Market By Species
                 1.2.3.1. Global Pet Cancer Therapeutics Market Revenue and Growth Rate Comparison By Species (2015-2026)
                 1.2.3.2. Dogs
                 1.2.3.3. Cats
                 1.2.3.4. Others
       1.2.4. Pet Cancer Therapeutics Market By Cancer Type
                 1.2.4.1. Global Pet Cancer Therapeutics Market Revenue and Growth Rate Comparison By Cancer Type (2015-2026)
                 1.2.4.2. Melanoma
                 1.2.4.3. Squamous Cell Cancer
                 1.2.4.4. Mast Cell Cancer
                 1.2.4.5. Mammary
                 1.2.4.6. Lymphoma
                 1.2.4.7. Others
       1.2.5. Pet Cancer Therapeutics Market by Geography
                 1.2.5.1. Global Pet Cancer Therapeutics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
                 1.2.5.2. North America Pet Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)
                 1.2.5.3. Europe Pet Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)
                 1.2.5.4. Asia-Pacific Pet Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)
                 1.2.5.5. Latin America Pet Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)
                 1.2.5.6. Middle East and Africa (MEA) Pet Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
       2.4.1. Bargaining Power of Suppliers
       2.4.2. Bargaining Power of Buyers
       2.4.3. Threat of Substitute
       2.4.4. Threat of New Entrants
       2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
       2.6.1. Raw Material and Suppliers
       2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
       2.8.1. Player Positioning Analysis
       2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Pet Cancer Therapeutics Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Pet Cancer Therapeutics Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Pet Cancer Therapeutics Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Pet Cancer Therapeutics Major Manufacturers in 2017

CHAPTER 4. PET CANCER THERAPEUTICS MARKET BY MEDICINE TYPE

4.1. Global Pet Cancer Therapeutics Revenue By Medicine Type
4.2. Vaccines
       4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Chemotherapy Drugs
       4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Other
       4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. PET CANCER THERAPEUTICS MARKET BY SPECIES

5.1. Global Pet Cancer Therapeutics Revenue By Species
5.2. Dogs
       5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Cats
       5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
       5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. PET CANCER THERAPEUTICS MARKET BY CANCER TYPE

6.1. Global Pet Cancer Therapeutics Revenue By Cancer Type
6.2. Melanoma
       6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Squamous Cell Cancer
       6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Mast Cell Cancer
       6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Mammary
       6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Lymphoma
       6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.7. Others
       6.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA PET CANCER THERAPEUTICS MARKET BY COUNTRY

7.1. North America Pet Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Pet Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
       7.3.1. U.S. Pet Cancer Therapeutics Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
       7.3.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
       7.3.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
7.4. Canada
       7.4.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
       7.4.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
       7.4.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
7.5. Mexico
       7.5.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
       7.5.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
       7.5.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE PET CANCER THERAPEUTICS MARKET BY COUNTRY

8.1. Europe Pet Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Pet Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
       8.3.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
       8.3.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
       8.3.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
8.4. Germany
       8.4.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
       8.4.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
       8.4.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
8.5. France
       8.5.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
       8.5.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
       8.5.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
8.6. Spain
       8.6.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
       8.6.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
       8.6.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
8.7. Rest of Europe
       8.7.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
       8.7.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
       8.7.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC PET CANCER THERAPEUTICS MARKET BY COUNTRY

9.1. Asia-Pacific Pet Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Pet Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
       9.3.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
       9.3.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
       9.3.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
9.4. Japan
       9.4.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
       9.4.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
       9.4.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
9.5. India
       9.5.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
       9.5.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
       9.5.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
9.6. Australia
       9.6.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
       9.6.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
       9.6.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
9.7. South Korea
       9.7.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
       9.7.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
       9.7.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
       9.8.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
       9.8.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
       9.8.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA PET CANCER THERAPEUTICS MARKET BY COUNTRY

10.1. Latin America Pet Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Pet Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
         10.3.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
         10.3.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
         10.3.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
10.4. Argentina
         10.4.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
         10.4.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
         10.4.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
10.5. Rest of Latin America
         10.5.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
         10.5.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
         10.5.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST PET CANCER THERAPEUTICS MARKET BY COUNTRY

11.1. Middle East Pet Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Pet Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
         11.3.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
         11.3.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
         11.3.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
11.4. UAE
         11.4.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
         11.4.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
         11.4.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
11.5. Rest of Middle East
         11.5.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
         11.5.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
         11.5.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA PET CANCER THERAPEUTICS MARKET BY COUNTRY

12.1. Africa Pet Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Pet Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
         12.3.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
         12.3.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
         12.3.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
12.4. Egypt
         12.4.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
         12.4.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
         12.4.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)
12.5. Rest of Africa
         12.5.1. Market Revenue and Forecast By Medicine Type, 2015 - 2026 ($Million)
         12.5.2. Market Revenue and Forecast By Species, 2015 - 2026 ($Million)
         12.5.3. Market Revenue and Forecast By Cancer Type, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Aratana Therapeutics
         13.1.1. Company Snapshot
         13.1.2. Overview
         13.1.3. Financial Overview
         13.1.4. Type Portfolio
         13.1.5. Key Developments
         13.1.6. Strategies
13.2. Vetivax
         13.2.1. Company Snapshot
         13.2.2. Overview
         13.2.3. Financial Overview
         13.2.4. Type Portfolio
         13.2.5. Key Developments
         13.2.6. Strategies
13.3. Regeneus
         13.3.1. Company Snapshot
         13.3.2. Overview
         13.3.3. Financial Overview
         13.3.4. Type Portfolio
         13.3.5. Key Developments
         13.3.6. Strategies
13.4. Zoetis
         13.4.1. Company Snapshot
         13.4.2. Overview
         13.4.3. Financial Overview
         13.4.4. Type Portfolio
         13.4.5. Key Developments
         13.4.6. Strategies
13.5. AB Science
         13.5.1. Company Snapshot
         13.5.2. Overview
         13.5.3. Financial Overview
         13.5.4. Type Portfolio
         13.5.5. Key Developments
         13.5.6. Strategies
13.6. Merial
         13.6.1. Company Snapshot
         13.6.2. Overview
         13.6.3. Financial Overview
         13.6.4. Type Portfolio
         13.6.5. Key Developments
         13.6.6. Strategies
13.7. VetDC
         13.7.1. Company Snapshot
         13.7.2. Overview
         13.7.3. Financial Overview
         13.7.4. Type Portfolio
         13.7.5. Key Developments
         13.7.6. Strategies
13.8. Others
         13.8.1. Company Snapshot
         13.8.2. Overview
         13.8.3. Financial Overview
         13.8.4. Type Portfolio
         13.8.5. Key Developments
         13.8.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
         14.1.1. Initial Data Search
         14.1.2. Secondary Research
         14.1.3. Primary Research
14.2. Assumptions and Scope

Cart Summary